These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 34809540)

  • 1. Theranostic Applications of Nanomaterials in Alzheimer's Disease: A Multifunctional Approach.
    Tripathi P; Shukla P; Bieberich E
    Curr Pharm Des; 2022; 28(2):116-132. PubMed ID: 34809540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The application of multifunctional nanomaterials in Alzheimer's disease: A potential theranostics strategy.
    Xu Y; Zhao M; Zhou D; Zheng T; Zhang H
    Biomed Pharmacother; 2021 May; 137():111360. PubMed ID: 33582451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2D Nanomaterials for Cancer Theranostic Applications.
    Cheng L; Wang X; Gong F; Liu T; Liu Z
    Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
    Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
    Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantum dots as a theranostic approach in Alzheimer's disease: a systematic review.
    Villalva MD; Agarwal V; Ulanova M; Sachdev PS; Braidy N
    Nanomedicine (Lond); 2021 Aug; 16(18):1595-1611. PubMed ID: 34180261
    [No Abstract]   [Full Text] [Related]  

  • 6. Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective.
    Ahmad J; Akhter S; Rizwanullah M; Khan MA; Pigeon L; Addo RT; Greig NH; Midoux P; Pichon C; Kamal MA
    Curr Alzheimer Res; 2017; 14(11):1164-1181. PubMed ID: 28482786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near-infrared II theranostic agents for the diagnosis and treatment of Alzheimer's disease.
    Zhou C; Zeng F; Yang H; Liang Z; Xu G; Li X; Liu X; Yang J
    Eur J Nucl Med Mol Imaging; 2024 Aug; 51(10):2953-2969. PubMed ID: 38502215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theranostic applications of nanoparticles in neurodegenerative disorders.
    Ramanathan S; Archunan G; Sivakumar M; Tamil Selvan S; Fred AL; Kumar S; Gulyás B; Padmanabhan P
    Int J Nanomedicine; 2018; 13():5561-5576. PubMed ID: 30271147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional nanomedicine with silica: Role of silica in nanoparticles for theranostic, imaging, and drug monitoring.
    Chen F; Hableel G; Zhao ER; Jokerst JV
    J Colloid Interface Sci; 2018 Jul; 521():261-279. PubMed ID: 29510868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics.
    Nguyen KT; Zhao Y
    Acc Chem Res; 2015 Dec; 48(12):3016-25. PubMed ID: 26605438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomaterials that Aid in the Diagnosis and Treatment of Alzheimer's Disease, Resolving Blood-Brain Barrier Crossing Ability.
    Song Q; Li J; Li T; Li HW
    Adv Sci (Weinh); 2024 Oct; 11(38):e2403473. PubMed ID: 39101248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendrimer Architectonics to Treat Cancer and Neurodegenerative Diseases with Implications in Theranostics and Personalized Medicine.
    Moorthy H; Govindaraju T
    ACS Appl Bio Mater; 2021 Feb; 4(2):1115-1139. PubMed ID: 35014470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Assessment of In-vitro and In-vivo Evaluation Methods for Theranostic Nanomaterials.
    Parashar P; Singh N; Alka ; Maurya P; Saraf SA
    Curr Pharm Des; 2022; 28(2):78-90. PubMed ID: 34348616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor-Targeted Surface-Engineered Nanomaterials for Breast Cancer Imaging and Theranostic Applications.
    Ahmad J; Rizwanullah M; Suthar T; Albarqi HA; Ahmad MZ; Vuddanda PR; Khan MA; Jain K
    Crit Rev Ther Drug Carrier Syst; 2022; 39(6):1-44. PubMed ID: 35997100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders.
    Sim TM; Tarini D; Dheen ST; Bay BH; Srinivasan DK
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances in Theranostic Applications of Nanomaterials in Cancer.
    Ahmed F; Khan MA; Haider N; Ahmad MZ; Ahmad J
    Curr Pharm Des; 2022; 28(2):133-150. PubMed ID: 34530703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
    Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; Grazú V; Borm P; Estrada G; Ntziachristos V; Razansky D
    Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of Current Strategies for Delivering Alzheimer's Disease Drugs across the Blood-Brain Barrier.
    Wong KH; Riaz MK; Xie Y; Zhang X; Liu Q; Chen H; Bian Z; Chen X; Lu A; Yang Z
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics.
    Rabaan AA; Bukhamsin R; AlSaihati H; Alshamrani SA; AlSihati J; Al-Afghani HM; Alsubki RA; Abuzaid AA; Al-Abdulhadi S; Aldawood Y; Alsaleh AA; Alhashem YN; Almatouq JA; Emran TB; Al-Ahmed SH; Nainu F; Mohapatra RK
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36557793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Versatile nanomaterials for Alzheimer's disease: Pathogenesis inspired disease-modifying therapy.
    Xi Y; Chen Y; Jin Y; Han G; Song M; Song T; Shi Y; Tao L; Huang Z; Zhou J; Ding Y; Zhang H
    J Control Release; 2022 May; 345():38-61. PubMed ID: 35257810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.